← Leaderboards
Tibor Keler
Celldex Therapeutics, Inc.
$4,514,018
Attributed
$6,742,436
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2011–21$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$6,742,436 · 3
By mechanism
R44$6,444,864 · 2
R43$297,572 · 1
Top collaborators
- Chandan Guha4 shared
Others in their field
Top investigators on “Immune”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmuneDendritic CellsResponseCollaborationsImmune ResponseBiotechnologyClinical TrialsPre-ClinicalInstitutionProgramsSmall Business Innovation Research GrantSafetyImmunityT-LymphocyteRegimenBaseAntibodiesCytotoxicDisseminated Malignant NeoplasmEarly TreatmentImmunoregulationCancer CellHematopoietic Cell Growth FactorsBlood
Grant awards (7)
Immune modulation of radiation therapy with Flt3 ligand$1,631,702
R44 · FY2021 · CA · contact PI
Immune modulation of radiation therapy with Flt3 ligand$1,204,513
R44 · FY2020 · CA · contact PI
Immune modulation of radiation therapy with Flt3 ligand$538,873
R44 · FY2016 · CA · contact PI
Immune modulation of radiation therapy with Flt3 ligand$1,081,749
R44 · FY2015 · CA · contact PI
Dendritic Cell-Targeted HIV Vaccine Product$988,487
R44 · FY2015 · AI · contact PI
Dendritic Cell-Targeted HIV Vaccine Product$999,540
R44 · FY2014 · AI · contact PI
Dendritic Cell-Targeted HIV Vaccine Product$297,572
R43 · FY2011 · AI · contact PI